AEON Biopharma Inc AEON

US N/A
$0.26 β–² +1.31% (+$0.00)
⬆️ Above Yest. High 🔥 High Short Interest
Open $0.26
Prev Close $0.26
Day Range $0.26 – $0.27
52W Range $0.18 – $1.45
Market Cap $13.15M
Beta 0.65
EPS (TTM) $-3.58

πŸ“‹ Company Profile

IndustryN/A
CountryUS
ExchangeNASDAQ NMS - GLOBAL MARKET
CurrencyUSD
IPO Date2021-10-08
Shares Out.37,155,500
Websiteaeonbiopharma.com/ β†—
Phone19492844555.0
Employees8
Revenue$0
Gross Profit$0
Net Income-$1.2M
Free Cash Flow-$13.6M
Total Assets$5.9M
Total Liabilities$21.3M
Equity-$15.4M
About AEON Biopharma Inc

AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.

AEON Biopharma Inc is a publicly traded company under the ticker symbol AEON on the NASDAQ NMS - GLOBAL MARKET, operating in the N/A industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.

πŸ“Š Analyst Ratings

9 analysts (2026-09-01)

Strong Buy 2
Buy 6
Hold 1

πŸ“° Latest News for AEON

πŸ‘₯ Related Stocks